TwinStrand Biosciences

📍 Seattle, United States👥 64 employees💰 Last funded Jan 2020
Biotechnology Research🌐 twinstrandbio.com
Website LinkedIn
We are a vibrant young company committed to science first. Our mission is to develop and deliver the unprecedented accuracy of TwinStrand Duplex Sequencing® technology for applications in clinical medicine and life sciences where it can do the greatest good for the greatest number of people. Our approach is multifaceted and encompasses internal development projects, external collaborations and empowering of partner organizations. TwinStrand Duplex Sequencing® technology is an ultra-high accuracy, error-corrected sequencing method that overcomes the limitations of NGS by independently tracking both strands of individual DNA molecules. Utilizing our multi-patented novel chemistry and cloud-based bioinformatics, the paired sequences are compared to eliminate errors, reducing error rates from 1-in-100 to 1-in-10 million, revealing ultra-low frequency variants.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in TwinStrand Biosciences?
TwinStrand Biosciences has 2 investors on record on gritt.io.
When did TwinStrand Biosciences last raise funding?
The most recent investment in TwinStrand Biosciences recorded on gritt.io was in January 2020.
What industry is TwinStrand Biosciences in?
TwinStrand Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TwinStrand Biosciences based?
TwinStrand Biosciences is headquartered in Seattle, United States.